| MeSH term | MeSH ID | Detail |
|---|---|---|
| Lung Neoplasms | D008175 | 171 associated lipids |
| Acne Vulgaris | D000152 | 35 associated lipids |
| Cell Transformation, Neoplastic | D002471 | 126 associated lipids |
| Lymphoma, Large-Cell, Anaplastic | D017728 | 3 associated lipids |
Total
4
13-cis-retinoic acid,Isotretinoin
13-cis-retinoic acid,isotretinoin is a lipid of Prenol Lipids (PR) class. 13-cis-retinoic acid,isotretinoin is associated with abnormalities such as Dermatitis, Phototoxic. The involved functions are known as Regulation, Pigment, chromophore, Light absorption and Pupil constriction. 13-cis-retinoic acid,isotretinoin often locates in Neurosecretory Systems. The associated genes with 13-cis-retinoic acid,Isotretinoin are melanopsin.
Cross Reference
Introduction
To understand associated biological information of 13-cis-retinoic acid,Isotretinoin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with 13-cis-retinoic acid,Isotretinoin?
13-cis-retinoic acid,Isotretinoin is suspected in Dermatitis, Phototoxic and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 13-cis-retinoic acid,Isotretinoin
PubChem Associated disorders and diseases
What pathways are associated with 13-cis-retinoic acid,Isotretinoin
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with 13-cis-retinoic acid,Isotretinoin?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with 13-cis-retinoic acid,Isotretinoin?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with 13-cis-retinoic acid,Isotretinoin?
There are no associated biomedical information in the current reference collection.
What genes are associated with 13-cis-retinoic acid,Isotretinoin?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with 13-cis-retinoic acid,Isotretinoin?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with 13-cis-retinoic acid,Isotretinoin
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Lancaster PA | Teratogenicity of isotretinoin. | 1988 | Lancet | pmid:2903987 |
| Dwyer JM et al. | Vasculitis and retinoids. | 1989 | Lancet | pmid:2570197 |
| Reynolds P et al. | Delayed onset of vasculitis following isotretinoin. | 1989 | Lancet | pmid:2572922 |
| Clark RE et al. | Effect of 13-cis-retinoic acid on survival of patients with myelodysplastic syndrome. | 1987 | Lancet | pmid:2882180 |
| Tangrea JA et al. | Isotretinoin and the axial skeleton. | 1992 | Lancet | pmid:1354829 |
| Bunker CB et al. | Isotretinoin and eosinophilic pleural effusion. | 1989 | Lancet | pmid:2563806 |
| Harms M et al. | Isotretinoin ineffective topically. | 1985 | Lancet | pmid:2857449 |
| McBride WG | Limb reduction deformities in child exposed to isotretinoin in utero on gestation days 26-40 only. | 1985 | Lancet | pmid:2860473 |
| Harrington KJ et al. | Erythroplasia of Queyrat treated with isotretinoin. | 1993 | Lancet | pmid:8105246 |
| Tricot G | Effect of isotretinoin on survival of patients with myelodysplastic syndrome. | 1987 | Lancet | pmid:2884408 |
| Taylor AE | Dissecting cellulitis of the scalp: response to isotretinoin. | 1987 | Lancet | pmid:2885687 |
| Robert E | Isotretinoin dose and teratogenicity. | 1988 | Lancet | pmid:2893054 |
| Ayme S et al. | Isotretinoin dose and teratogenicity. | 1988 | Lancet | pmid:2894594 |
| French LE and Saurat JH | Treatment of cutaneous T-cell lymphoma by retinoids and calcitriol. | 1995 | Lancet | pmid:7623546 |
| Retinoids in dermatology. | 1981 | Lancet | pmid:6111638 | |
| van der Pijl JW et al. | Isotretinoin and azathioprine: a synergy that makes hair curl? | 1996 | Lancet | pmid:8774605 |
| Saurat JH | Isotretinoin dosage. | 1996 | Lancet | pmid:8774606 |
| Aractingi S et al. | Post-isotretinoin vasculitis. | 1990 | Lancet | pmid:1967805 |
| James M | Isotretinoin for severe acne. | 1996 | Lancet | pmid:8656912 |
| Bécherel PA et al. | Mechanism of anti-inflammatory action of retinoids on keratinocytes. | 1994 | Lancet | pmid:7983967 |
| Alexander M | Treatment of mycosis fungoides with isotretinoin. | 1983 | Lancet | pmid:6135953 |
| Rosa FW | Teratogenicity of isotretinoin. | 1983 | Lancet | pmid:6136666 |
| Warrell RP et al. | Isotretinoin in cutaneous T-cell lymphoma. | 1983 | Lancet | pmid:6136780 |
| Braun JT et al. | Isotretinoin dysmorphic syndrome. | 1984 | Lancet | pmid:6142222 |
| Hill RM | Isotretinoin teratogenicity. | 1984 | Lancet | pmid:6145899 |
| Majewski S et al. | Combination of isotretinoin and calcitriol for precancerous and cancerous skin lesions. | 1994 | Lancet | pmid:7968149 |
| Thomsen K | Cutaneous T-cell lymphoma and calcitriol and isotretinoin treatment. | 1995 | Lancet | pmid:7791477 |
| Coleman R and MacDonald D | Effects of isotretinoin on male reproductive system. | 1994 | Lancet | pmid:7912796 |
| Mobacken H and Vahlquist A | [A 10-year perspective on isotretinoin therapy. Dramatic improvement in severe acne]. | 1993 | Lakartidningen | pmid:8366709 |
| Mobacken H et al. | [30 years with isotretinoin. "Miracle medicine" against acne with many side effects]. | 2014 Jan 15-28 | Lakartidningen | pmid:24552013 |
| Padoan SM | [Doubtful re-evaluation of Roaccutane]. | 2003 | Lakartidningen | pmid:12640993 |
| Pettersson U and Mjorndal T | [Roaccutane and inflammatory bowel disease]. | 2006 | Lakartidningen | pmid:17330604 |
| Gerdén B et al. | [The Medical Products Agency is following up Roaccutane to assure patients' safety]. | 2003 | Lakartidningen | pmid:12680028 |
| Bergman U and Rosholm JU | [Use of a drug registry. Can asthma be aggravated by tretinoin?]. | 1994 | Lakartidningen | pmid:7990547 |
| Beriat GK et al. | Evaluation of the clinical effects of isotretinoin on chronic rhinosinusitis. | 2011 Sep-Oct | Kulak Burun Bogaz Ihtis Derg | pmid:21919829 |
| Heuberger A and Büchi ER | [Irreversible cataract as a possible side effect of isoretinoin]. | 1994 | Klin Monbl Augenheilkd | pmid:8051901 |
| Schaier M et al. | Isotretinoin alleviates renal damage in rat chronic glomerulonephritis. | 2001 | Kidney Int. | pmid:11737596 |
| Datta PK and Lianos EA | Retinoic acids inhibit inducible nitric oxide synthase expression in mesangial cells. | 1999 | Kidney Int. | pmid:10432387 |
| Chang HC and Samokyszyn VM | Biotransformation of 13(Z)-retinoic acid in mouse skin and human keratinocyte cultures. | 2000 | Kaohsiung J. Med. Sci. | pmid:11221542 |
| Huoh KC and Chang KW | Lip abscess associated with isotretinoin treatment of acne vulgaris. | 2013 | JAMA Dermatol | pmid:23760516 |
| Kaplan R et al. | A case of isotretinoin-induced purpura annularis telangiectodes of Majocchi and review of substance-induced pigmented purpuric dermatosis. | 2014 | JAMA Dermatol | pmid:24284887 |
| McIntee TJ and Bruckner AL | Challenges in optimizing isotretinoin use for acne vulgaris. | 2013 | JAMA Dermatol | pmid:24172999 |
| Blasiak RC et al. | High-dose isotretinoin treatment and the rate of retrial, relapse, and adverse effects in patients with acne vulgaris. | 2013 | JAMA Dermatol | pmid:24173086 |
| Gavrilova M et al. | Eruption in a patient with Crohn disease. | 2013 | JAMA Dermatol | pmid:23324767 |
| Tintle SJ et al. | Safe Use of Therapeutic-Dose Oral Isotretinoin in Patients With a History of Pseudotumor Cerebri. | 2016 | JAMA Dermatol | pmid:26580859 |
| Altman EM | Isotretinoin and pregnancy prevention: do we need to take a long, hard look at ourselves? | 2014 | JAMA Dermatol | pmid:24258339 |
| Werner CA et al. | Women's experiences with isotretinoin risk reduction counseling. | 2014 | JAMA Dermatol | pmid:24258663 |
| Krishna S et al. | Influence of ω-3 fatty acids on triglyceride levels in patients using isotretinoin. | 2015 | JAMA Dermatol | pmid:25251777 |
| Etminan M et al. | Isotretinoin and risk for inflammatory bowel disease: a nested case-control study and meta-analysis of published and unpublished data. | 2013 | JAMA Dermatol | pmid:23426479 |
| Popescu CM and Bigby M | The weight of evidence on the association of isotretinoin use and the development of inflammatory bowel disease. | 2013 | JAMA Dermatol | pmid:23426480 |